Literature DB >> 9482272

Age-related development of gamma-aminobutyric acid (GABA)B receptor functions in various brain regions of spontaneously hypertensive rats.

T Ichida1, K Kuriyama.   

Abstract

The age-related development of GABAB receptors and their coupling to adenylate cyclase were studied in the brains of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Compared with WKY rats, the specific [3H]GABA binding to GABAB receptors showed a significant decrease not only in the posterior hypothalamus, midbrain, hippocampus and striatum of eleven-week-old SHR, which maintain a hypertensive state, but also in the posterior hypothalamus of four-week-old normotensive SHR. Similarly, the GABAB receptor agonists (baclofen and DN-2327)-induced suppression of adenylate cyclase activity showed a decrease in the posterior hypothalamus of four-week-old SHR as well as in the posterior hypothalamus and striatum of eleven-week-old SHR. These results suggest that the functions of the GABAB receptor in the brain of SHR may be decreased independently from the occurrence of blood pressure elevation and that such changes may even be involved in the pathogenesis of SHR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482272     DOI: 10.1023/a:1022409722274

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  GABAergic mechanisms in blood pressure control. A pharmacological analysis in the rat.

Authors:  B Persson
Journal:  Acta Physiol Scand Suppl       Date:  1980

2.  Reductions in blood pressure, heart rate and renal sympathetic nerve discharge in cats after the central administration of muscimol, a GABA agonist.

Authors:  M J Antonaccio; L Kerwin; D G Taylor
Journal:  Neuropharmacology       Date:  1978-10       Impact factor: 5.250

3.  Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327.

Authors:  T Wada; R Nakajima; E Kurihara; S Narumi; Y Masuoka; G Goto; Y Saji; N Fukuda
Journal:  Jpn J Pharmacol       Date:  1989-03

4.  Central antihypertensive properties of muscimol and related gamma-aminobutyric acid agonists and the interaction of muscimol with baroreceptor reflexes.

Authors:  C S Sweet; H C Wenger; D M Gross
Journal:  Can J Physiol Pharmacol       Date:  1979-06       Impact factor: 2.273

5.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

6.  Enhanced pressor response to GABA in the nucleus tractus solitarii of the spontaneously hypertensive rat.

Authors:  J M Catelli; A F Sved
Journal:  Eur J Pharmacol       Date:  1988-07-07       Impact factor: 4.432

7.  Decreased hypothalamic and medullary GABA turnover in spontaneously hypertensive rats.

Authors:  S Sasaki; T Kuwabara; T Yoshitomi; Y Yoneda; K Takenaka; T Takesako; M Tanaka; M Hirata; S Tanabe; T Nakata
Journal:  Cardiovasc Res       Date:  1992-03       Impact factor: 10.787

8.  Association and agonistic action of DN-2327, a novel isoindoline derivative, GABAB receptor in brain.

Authors:  T Ichida; M Hirouchi; H Mizutani; R Narihara; K Kuriyama
Journal:  Eur J Pharmacol       Date:  1994-03-15       Impact factor: 4.432

9.  Inhibition of GABAB receptor binding by guanyl nucleotides.

Authors:  D R Hill; N G Bowery; A L Hudson
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

10.  Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices.

Authors:  G R Seabrook; W Howson; M G Lacey
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

View more
  1 in total

1.  Increased GABA B receptor subtype expression in the nucleus of the solitary tract of the spontaneously hypertensive rat.

Authors:  Emma J Spary; Azhar Maqbool; Sikha Saha; Trevor F C Batten
Journal:  J Mol Neurosci       Date:  2008-03-13       Impact factor: 3.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.